A carregar...
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer
SIMPLE SUMMARY: New blood vessel formation (angiogenesis) has a crucial role in tumour growth and spread. Bevacizumab is an anticancer therapy that targets angiogenesis by inhibiting the vascular endothelial growth factor (VEGF) and is approved for the treatment of metastatic breast cancer. However,...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8307791/ https://ncbi.nlm.nih.gov/pubmed/34298725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143511 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|